Recent advances to evaluate anti-diabetic medicinal plants

Medicinal Plants: Biodiversity and Drugs

Volumn , Issue , 2012, Pages 526-569

  Fawzi, Mahomoodally Mohamad ^a  

^a UNIVERSITY OF MAURITIUS   (Mauritius)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869490091     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (217)

1. Abbasi, M.A., V.U. Ahmad, M. Zubair, M.A. Rashid, S.N. Khan, U. Farooq, M.I. Choudhary and K. Zeller. 2005. A new Glucosidase inhibiting dithiadiazetidin derivative from Symplocos racemosa. Heterocycles 65: 1837-1842.
2. Ahmad, N., M.R. Hassan, H. Halder and K.S. Bennoor. 1999. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bang. Med. Res. Council Bull. 25: 11-13.
3. Ahmed, F. and A. Urooj. 2010. In vitro studies on the hypoglycemic potential of Ficus racemosa stem bark. J. Sci. Food Agr. 90: 397-401.
4. Affourtit, C. and M.D. Brand. 2006. Stronger control of ATP/ADP by proton leak in pancreatic β-cells than skeletal muscle mitochondria. Biochem. J. 393: 151-159.
5. Affourtit, C. and M.D. Brand. 2008. Uncoupling protein-2 contributes significantly to high mitochondrial proton leak in INS-1E insulinoma cells and attenuates glucose-stimulated insulin secretion. Biochem. J. 409: 199-204.
6. Al-Habori, M., A.M. Al-Aghban and M. Al-Mamary. 2001. Effect of fenugreek extracts on intestinal sodium dependent glucose uptake and hepatic glycogen metabolism in vitro. Int. J. Exp. Diab. Res. 2: 91-99.
7. Ali, H., P.J. Houghton and A. Soumyanath. 2006. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J. Ethnopharmacol. 107: 449-455.
8. Alison, D. and G. Flatt. 1991. World Health Organization. Guidelines for the assessment of herbal medicines. Programme on traditional medicines. WHO/TRM/91.4.
9. Anandharajan, R., K. Pathmanathan, N.P. Shankernarayanan, R.A. Viswakarma and A. Balakrishnan. 2005. Upregulation of Glut-4 and PPARγ by an isoflavone from Pterocarpus marsupium on L6 myotubes: a possible mechanism of action. J. Ethnopharmacol. 97:253-260.
10. Ang-lee, M.K., J. Moss and C.S. Yuan. 2001. Herbal medicines and perioperative care. J. Am. Med. Assoc. 286: 208-216.
11. Anis, E., I. Anis, S. Ahmed, G. Mustafa, A. Malik, N. Afza, S.M.A. Hai, S. Shahzad-ul-Hussan and M.I. Choudhary. 2002. α-Glucosidase inhibitory constituents from Cuscuta reflexa. Chem. Pharm. Bull. 50: 112-114.
12. Apostolidis, E., Y. Kwon and K. Shetty. 2006. Potential of cranberry- based herbal synergies for diabetes and hypertension management. Asia Pac. J. Clin. Nutr. 15: 433-441.
13. Arambewela, L.S.R., L.D.A.M. Arawwawala and W.D. Ratnasooriya. 2005. Antidiabetic activities of aqueous and ethanolic extracts of Piper beetle leaves in rats. J. Ethnopharmacol. 102:239-245.
14. Aronson, D. and E.J. Rayfield. 2002. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardio. Diab. 1: 1-1.
15. Ashcroft, F.M. and P. Rorsman. 2004. Molecular defects in insulin secretion in type-2 diabetes. Rev. Endocr. Metab. Disord. 5: 135-142.
16. Austin, J.A. 1998. Why patients use alternative medicine. J. Am. Med. Assoc. 256:1548-1553.
17. Bagghi, A.K. 2001. Alternative medicine-old wine in a new bottle. J. Indi. Med. Assoc. 98:332-333.
18. Bailey, C. and C. Day. 1989. Traditional plant medicines as treatment for diabetes. Diab. Care 12: 553-564.
19. Balandrin, M.F., J.A. Klocke, E.S. Wurtele and W.H. Bollinger. 1985. Natural plant chemicals:Sources of industrial and medicinal materials. Sci. 228: 1154-1160.
20. Barrett, B., D. Kiefer and D. Rabago. 1999. Assessing the risks and benefits of herbal medicine:An overview of scientific evidence. Altern. Therap. 5: 40-49.
21. Bent, S. 2008. Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation. J. Gen. Intern. Med. 23: 854-859.
22. Bilous, R. and R. Donnelly. 2010. Handbook of Diabetes. 4th edn. Blackwell Publishing Ltd. UK.
23. Blumenthal, M., W.R. Busse, A. Goldberg, J. Gruenwald, T. Hall, S. Klein, C.W. Riggins and R.S. Risher. 1998. The complete German Commission E. Monographs: Therapeutic guide to herbal medicines. Amer. Bot. 10: 100-167.
24. Bnouham, M., F.Z. Merhfour, A. Ziyyat, M. Aziz, A. Legssyer and H. Mekhfi. 2010. Antidiabetic effect of some medicinal plants of Oriental Morocco in neonatal non-insulin dependent diabetes mellitus rats. Hum. Exp. Toxicol. 1-7.
25. Bopana, N. and S. Saxena. 2007. Asparagus racemosus-ethnopharmacological evaluation and conservation needs. J. Ethnopharmacol. 110: 1-15.
26. Bouche, C., S. Serdy, C.R. Kahn and A.B. Goldfine. 2004. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr. Rev. 25: 807-830.
27. Büyükbalci, A. and S. Nehir. 2008. Determination of in vitro antidiabetic effects, antioxidant activities and phenol contents of some herbal teas. Plant Foods Hum. Nutri. 63: 27-33.
28. Chakrabarti, S., T.K. Biswas, B. Rokeya, M. Mosihuzzaman, L. Ali, N. Nahar and B. Mukherjee. 2003. Advanced studies on hypoglycemic effect of Caesalpinia bonducella F. in type 1 and 2 diabetes in Long-Evans rats. J. Ethnopharmacol. 84: 41-46.
29. Chakrabarti, S., T.K. Biswas, T. Seal, R. Begum, A. Liquat, A.K. Azad Khan, N. Nahar, M. Mosihuzzaman and B. Mukherjee. 2005. Antidiabetic activity of Caesalpinia bonducella F. in chronic type 2 diabetic model in Long-Evans rats and evaluation of insulin secretagogue property of its fractions on isolated islets. J. Ethnopharmacol. 97:117-122.
30. Chan, C.M., Y.W. Chan, C.H. Lau, T.W. Lau, K.M. Lau, F.C. Lam, C.T. Che, P.C. Leung, K.P. Fung, C.B.S. Lau and Y.Y. Ho. 2007. Influence of an anti-diabetic foot ulcer formula and its component herbs on tissue and systemic glucose homeostasis. J. Ethnopharmacol. 109: 10-20.
31. Choate, C. 1998. Modern medicine and traditional Chinese medicine-Diabetes mellitus. J. Chin. Med. 58: 1-9.
32. Conforti, F., G. Statti, M.R. Loizzo, G. Sacchetti, F. Poli and F. Menichini. 2005a. In vitro antioxidant effect and inhibition of α-amylase of two varieties of Amaranthus caudatus Seeds. Biol. Pharm. Bull. 28: 1098-1102.
33. Conforti, F., M.R. Loizzo, G.A. Statti and F. Menichini. 2005b. Comparative radical scavenging and antidiabetic activities of methanolic extract and fractions from Achillea ligustica ALL. Biol. Pharm. Bull. 28: 1791-1794.
34. Cyrus, T., D. Pratico, L. Zhao, J.L. Witztum, D.J. Rader, J. Rokach, G.A. Fitzgerald and C. Funk. 2001. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation 103: 2277-2282.
35. Defronzo, R.A. 1999. Pharmacologic Therapy for Type 2 Diabetes Mellitus. Ann. Intern. Med. 131: 281-303.
36. Deutschländer, M.S., M. Van de Venter, S. Roux, J. Louw and N. Lall. 2009. Hypoglycemic activity of four plant extracts traditionally used in South Africa for diabetes. J. Ethnopharmacol. 124: 619-624.
37. Evans, J.L., I.D. Goldfine, B.A. Maddux and G.M. Grodsky. 2002. Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes. Endocri. Rev. 23: 599-622.
38. Farnsworth, N.R. and A.B. Segelman. 1971. Hypoglycaemic plants. Tile Till. 57: 41-56.
39. Farsi, D.S., C.S. Harris, L. Reid, A.L. Steffany-Bennett, P.S. Haddad, L.C. Martineau and J.T. Arnason. 2008. Inhibition of non-enzymatic glycation by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays). Phytother. Res. 22: 108-112.
40. Fernandes, A., D. Cromarty, C. Albrecht, E. Jansen and V. Rensburg. 2005. The antioxidant potential of Sutherlandia frutescens. J. Ethnopharmacol. 95: 1-5.
41. Fröde, T.S. and Y.S. Medeiros. 2008. Animal models to test drugs with potential antidiabetic activity. J. Ethnopharmacol. 115: 173-183.
42. Fukumoto, H., T. Kayano, J.B. Buse, Y. Edwards, P.F. Pilch, G.I. Bell and S. Seino. 1989. Cloning and characterization of the major insulin responsive glucose transporter expressed in human skeletal muscle and other insulin responsive tissues. J. Biol. Chem. 264:7776-7779.
43. Gad, M.Z., M.M. El-Sawalhi, M.F. Ismail and N.D. El-Tanbouly. 2006. Biochemical study of the anti-diabetic action of the Egyptian plants: Fenugreek and Balanites. Mol. Cell. Biochem. 281: 173-183.
44. Gallagher, A.M., P.R. Flatt, G. Duffy and Y.H.A. Abdel-Wahab. 2003. The effects of traditional antidiabetic plants on in vitro glucose diffusion. Nutr. Res. 23: 413-424.
45. Gebhardt, R. 2000. In vitro screening of plant extracts and phytopharmaceuticals: novel approach for the elucidation of active compounds and their mechanism. Planta Med. 66: 99-105.
46. Geng, P., Y. Yang, Z. Gao, Y. Yu, Q. Shi and G. Bai. 2007. Combined effect of total alkaloids from Feculae bombycis and natural flavonoids on diabetes. J. Pharm. Pharmacol. 59: 1145-50.
47. Georgetti, S.R., R. Casagrande, F.T.M.C. Vicentini, W.A. Verri and M.J.V. Fonseca. 2006. Evaluation of the antioxidant activity of soybean extract by different in vitro methods and investigation of this activity after its incorporation in topical formulations. Eur. J. Pharm. Biopharm. 64: 99-106.
48. Gireesh, G., T. Santhosh, B. Joseph and C.S. Paulose. 2009. Antihyperglycemic and insulin secretory activity of Costus pictus leaf extract in streptozotocin induced diabetic rats and in vitro pancreatic islet culture. J. Ethnopharmacol. 123: 470-474.
49. Goldman, P. 2001. Herbal medicines today and the roots of modern pharmacology. Complement. Altern. Med. 135: 594-600.
50. Green, K., M.D. Brand and M.P. Murphy. 2004. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diab. 53:110-118.
51. Grover, J.K., S. Yadav and V. Vats. 2002. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 81: 81-100.
52. Guilliams, T.G. 2002. Diabetes-The preventable epidemic. The Standard 5: 1-7.
53. Gulcin, I., O.I. Kufrevioglu, M. Oktay and M.E. Buyukokuroglu. 2004. Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle (Urtica dioica L.). J. Ethnopharmacol. 90: 205-15.
54. Gundersen, L.L., K.E. Malterud, A.H. Negussie, F. Rise, S. Teklu and O.B. Ostby. 2003. Indolizines as novel potent inhibitors of 15-lipoxygenase. Bioorg. Med. Chem. 11:5409-5415.
55. Hamdan, I. and F. Afifi. 2004. Studies on the in vitro and vivo hypoglycaemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J. Ethnopharmacol. 93: 117-121.
56. Hamdan, N. and S.J.H. Ashcroft. 1998. Pharmacologocal characterization of the antihyperglycemic properties of Tinospora crispa extract. J. Ethnopharmacol. 62: 7-13.
57. Hanamura, T., C. Mayama, H. Aoki, Y. Hirayama and M. Shimizu. 2006. Antihyperglycemic effect of polyphenols from Acerola (Malpighia emarginata DC.) fruit. Biosci. Biotechnol. Biochem. 70(8): 1813-1820.
58. Hanefeld, M. The role of alpha-glucosidase inhibitors (acarbose) pp. 143-152. In:C.E. Mogensen [ed.]. 2007. Pharmacotherapy of diabetes: new development. Springer, Berlin. Germany.
59. Harbilas, D., L.C. Martineau, C.S. Harris, D.C.A. Adeyiwola-Spoor, A. Saleem, J. Lambert, D. Caves, T. Johns, M. Prentki, A. Cuerrier, J.T. Arnason, S.A.L. Bennett and P.S. Haddad. 2009. Evaluation of the anti-diabetic potential of selected medicinal plant extracts from the Canadian Boreal Forest used to treat symptoms of diabetes: Part II. Can. J. Physiol. Pharmacol. 87: 479-492.
60. Heacock, P.M., R.H. Steven, A.J. Williams and W.B. Wolf. 2005. Effects of a medical food containing herbal α-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults. J. Amer. Diet. Assoc. 105: 67-71.
61. Hediger, M.A. and D.B. Rhoads. 2000. Molecular physiology of sodium-glucose cotransporters. Physiol. Rev. 74: 993-1026.
62. Hersberger, M. 2010. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis:leukotrienes, lipoxins and resolvins. Clin. Chem. Lab. Med. 48: 1063-1073.
63. Hideaki, K., T. Matsuoka, Y. Hakatani, D. Kawamorl, M. Matsuhisa and Y. Yamasaki. 2005. Oxidative Stress and the JNK Pathway in Diabetes. Cur. Diab. Rev. 1: 65-72.
64. Hikino, H., M. Ishiyama, Y. Suzuki and C. Konno. 1989a. Mechanism of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med. 55: 423-428.
65. Hikino, H., C. Kinno, Y. Mirin and T. Hayashi. 1989b. Mechanisms of hypoglycemic activity of actonitan A, a glycan from Aconitum carmichaeli roots. J. Ethnopharmacol. 25: 295-304.
66. Hostettmann, K. 1999. Strategy for the biological and chemical evaluation of plant extracts. IUPAC pp. 1-9. http://www.iupac.org/symposia/proceedings/phuket97/hostettmann.html. (Dec 2010)
67. Houghton, P.J., A.Y. Hylands, A. Mensah, A.M. Hensel and P. Deters. 2005. In vitro tests and ethnopharmacological investigations: Wound healing as an example. J. Ethnopharmacol. 100: 100-107.
68. Houghton, P.J., M.J. Howes, C.C. Lee and G. Steventon. 2007. Uses and abuses of in vitro tests in ethnopharmacology: visualizing an elephant. J. Ethnopharmacol. 110: 391-400.
69. Hsieh, C., L. Yuh-Charn, W.S. Ko, P. Chiung-Hui, H. Chien-Ning and R.Y. Peng. 2005. Inhibitory effect of some selected nutraceutic herbs on LDL glycation induced by glucose and glyoxal. J. Ethnopharmacol. 102: 357-363.
70. Imparl-Radosevich, J.S., M.M. Deas, D.A. Polansky, T.S. Baedke, T.S. Ingebrutsen, R.A. Anderson and D.J. Graves. 1998. Regulation of phosphotyrosine phosphatase (PTP-1) and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signaling. Hormone Res. 50: 177-182.
71. Jachak, S. 2002. Herbal drugs as antidiabetic. Crisps 3: 9-13.
72. Jaradat, M.S., D.J. Noonan, B. Wu, M.A. Avery and D.R. Feller. 2003. Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists. Planta Med. 68:667-671.
73. Johansen, J.S., A.K. Harris, D.J. Rychly and A. Ergul. 2004. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovas. Diab. 4:1475-2840.
74. Johnson, I.T., M. Jennifer, K.P. Gee, C. Caroyn and G.R. Fenwick. 1986. Influence of saponins on gut permeability and active nutrient transport in vitro. J. Nutri. 116: 2270-2277.
75. Johnston, K., P. Sharp, M. Clifford and L. Morgan. 2005. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Let. 579: 1653-1657.
76. Kamei, R., M. Kadokura, Y. Kitagawa, O. Hazeki and S. Oikawa. 2002. 2'-benzyloxychalcone derivatives stimulate glucose uptake in 3T3-L1 adipocytes. Life Sci. 73: 2091-2099.
77. Kang, K.A., S. Chae, S. Koh, J. Kim, J.H. Lee, H.J. You and J. Hyun. 2005. Protective effect of Puerariae radix on oxidative stress induced by hydrogen peroxide and streptozotocin. Biol. Pharm. Bull. 28: 1154-1160.
78. Kasi, R., B. Ramachandran and S. Subramanian. 2004. Protective effect of Eugenia jamblona seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 27: 1212-1217.
79. Kellet, G.L. and E. Brot-Laroche. 2005. Apical GLUT2: a major pathway of intestinal sugar absorption. Diab. 54: 3056-3062.
80. Khan, A., N.A. Bryden, M.M. Polansky and R.A. Anderson. 1990. Insulin potentiating factor and chromium content of selected foods and spices. Bio. Trace. Element Res. 24: 183-188.
81. Kikuchi, S., K. Shinpo, M. Takeuchi, S. Yamagishi, Z. Makita, N. Sasaki and K. Tashiro. 2003. Glycation-a sweet tempter for neuronal death. Brain Res. Dev. Brain Rev. 41: 306-323.
82. Kim, C.O. and K. Hoon-Eng. 1996. Insulinomimetic Effects Lipogenesis and Glucose of Myricetin on Transport in Rat Adipocytes but not Glucose Transporter I translocation. Biochem. Pharma. 51: 423-429.
83. Kim, H.Y. and J.H. Oh. 1999. Screening of Korean Forest Plants for Rat Lens Aldose Reductase Inhibition. Biosci. Biotech. Biochem. 63: 184-188.
84. Kimura, M., L. Waki, T. Chujo, T. Kikuchi, C. Hiyama, K. Yamazaki and O. Tanaka. 1981. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J. Pharm. 4: 410-417.
85. Kitagawa, R.R., M.S. Raddi, M.N. Khalil, W. Vilegas and L.M. Fonseca. 2003. Effect of the isocoumarin paepalantine on the luminol and lucigenin amplified chemiluminescence of rat neutrophils. Biol. Pharm. Bull. 26: 905-908.
86. Klein, R.L., M. Laimins and M.F. Lopes-Virella. 1995. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and non diabetic subjects. Diab. 44: 1093-1098.
87. Kobayashi, K., N. Funayama, R. Suzuki and F. Yoshizaki. 2002. Survey of the influence of chinese medicinal prescriptions on amylase activity in mouse plasma and gastrointestinal tube. Biol. Pharm. Bull. 25: 1108-1111.
88. Kobayashi, K., E. Baba, S. Fushiya, F. Takano, F. Batkhuu, T. Dash, C. Sanchir and S. Yoshisaki. 2003. Screening of Mongolian plants for influence on amylase activity in mouse plasma and gastrointestinal tube. Biol. Pharm. Bull. 26: 1045-1048.
89. Kotwaroo, I., M.F. Mahomoodally, A. Gurib-Fakim and A.H. Subratty. 2006. Effects of Arthocarpus heterophyllus on α-amylase activity in vitro. Phytother. Res. 20: 228-231.
90. Kyselova, P., M. Zourek, Z. Rusavy, L. Trefil and J. Racek. 2002. Hyperinsulinemia and oxidative stress. Physiol. Res. 51: 591-595.
91. Landmesser, U., D.G. Harrison and H. Drexler. 2005. Oxidant stress-a major cause of reduced endothelial nitric oxide availability in cardiovascular disease. Eur. J. Clin. Pharmacol. DOI 10.1007/s00228-005-0012.
92. Lapenna, D., G. Ciofani, S.D. Piedomenico, M.A. Giamberardino and F. Cuccurullo. 2003. Dihydrolipoic acid inhibits 15-lipoxygenase-dependent lipid peroxidation. Free Rad. Biol. Med. 35: 1203-1209.
93. Laville, M., D. Auboeuf, Y. Khalfallah, N. Vega, J.P. Riou and H. Vidal. 1996. Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J. Clin. Invest. 98: 43-49.
94. Lee, H.S. 2002. Inhibitory activity of Cinnamomum cassia bark-derived component against rat lens aldose reductase. J. Pharm. Pharma. Sci. 5: 226-230.
95. Lee, H., N.H. Won, K.H. Kim, H. Lee, W. Jun and K. Lee. 2005. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol. Pharm. Bull. 28: 1639-1644.
96. Li, Y., H. Matsuda and M. Yoshikawa. 1999. Effects of oleanolic acid glycosides on gastrointestinal transit and ileus in mice. Biol. Med. Chem. 7: 1201-1205.
97. Li, Y., S. Wen, B.P. Kota, G. Peng, G. Li, J. Yamharah and B.D. Roufogalis. 2005. Punica granatum flower extract, a potent -glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J. Ethnopharmacol. 99: 239-244.
98. Lipp, F. 1996. The efficacy, history, and politics of medicinal plants. Altern. Therap. 2: 36-40.
99. Liu, F., J.K. Kim, Y. Li, X. Liu, J. Li and X. Chen. 2001. An extract of Lagerstroemia speciosa has insulin-like glucose uptake-stimulatory and adipocytes differentiation-inhibitory activities in 3T3-L1 cells. J. Nutri. 131: 2242-2247.
100. Loo, D.D., E.M. Wright and T. Zeuthen. 2002. Water pumps. Rev. Physiol. 542: 53-60.
101. Loo, D.D., T. Zeuthen, G. Chandy and E.M. Wright. 1996. Cotransport of water by the Na+/ glucose Cotransport. Proc. Nat. Acad. Sci. 93: 13367-13370.
102. Loizzo, M.R., A.M. Saab, R. Tundis, F. Menichinia, M. Bonesia, V. Piccolo, G.A. Statti, B. Cindoc, P.J. Houghton and F. Menichinia. 2008. In vitro inhibitory activities of plants used in Lebanon traditional medicine against angiotensin converting enzyme (ACE) and digestive enzymes related to diabetes. J. Ethnopharmacol. 119: 109-116.
103. Liu, F., J.K. Kim, Y. Li, X. Liu, J. Li and X. Chen. 2001. An extract of Lagerstroemia speciosa has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J. Nutri. 131: 2242-2247.
104. Mahomoodally, M.F., A. Gurib-Fakim and A.H. Subratty. 2004a. A kinetic model for in-vitro intestinal uptake of L-tyrosine and D(+)-glucose across rat everted gut sacs in the presence of Momordica charantia, a medicinal plant used in traditional medicine against diabetes mellitus. J. Cell & Mol. Biol. 3: 39-44.
105. Mahomoodally, M.F., A. Gurib-Fakim and A.H. Subratty. 2004b. Experimental evidence for in vitro fluid transport in the presence of a traditional medicinal fruit extract across rat everted intestinal sacs. Fund. Clin. Pharmacol. 19: 87-92.
106. Mahomoodally, M.F., A. Gurib-Fakim and A.H. Subratty. 2004c. Momordica charantia extract inhibit uptake of monosaccharide and amino acid across rat everted gut sacs in-vitro. Biol. Pharm. Bull. 27: 216-218.
107. Mahomoodally, M.F., A. Gurib-Fakim and A.H. Subratty. 2005a. Effects of Ethrythroxylum macrocarpum on the transport of amino acids, glucose and fluids across rat everted guts sacs. Cell Mol. Biol. 4: 93-98.
108. Mahomoodally, M.F., A. Gurib-Fakim and A.H. Subratty. 2005b. Effects of Antidesma madagascariense on the transport of glucose, amino acid, fluid and electrolytes across rat everted intestinal sacs- comparable to insulin action in vitro. Bri. J. Biomed. Sci. 63:12-17.
109. Mahomoodally, M.F., A. Gurib-Fakim and A.H. Subratty. 2007. Effect of exogenous ATP on Momordica charantia Linn. (Cucurbitaceae) induced inhibition of D-glucose, L-tyrosine and fluid transport across rat everted intestinal sacs in vitro. J. Ethnopharmacol. 110:257-263.
110. Mahomoodally, M.F., A. Gurib-Fakim and A.H. Subratty. 2011. Inhibitory effects of a traditional antidiabetic medicinal fruit extract on the transport of inorganic phosphate and D-glucose across rat everted intestinal sacs- possible relationship with a “Crab-tree-effect”. J. Food Biochem. Accepted 22 July 2010.
111. Mahraoui, L., A. Rodolosse, A. Barbat, E. Dusaulx, A. Zweibaum, M. Rousset and E. Brot-Laroche. 1994. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem. J. 298: 629-633.
112. Malterud, K.E., T.L. Farbrot, A.E. Huse and R.B. Sund. 1993. Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacol. 47: 77-85.
113. Mao, W. and J. Kinsella. 1981. Amylase activity in banana fruit: properties and changes in activity with ripening. J. Food Sci. 46: 436-440.
114. Marles, R. and N.R. Farnsworth. 1995. Antidiabetic plants and their active constituents. Phytomedicines 2: 137-189.
115. Matthews, H.B., W.G. Lucier and K.D. Fisher. 1999. Medicinal herbs in the United States:Research needs. Env. Heal. Persp. 107: 773-778.
116. Mathiesen, L., K.E. Malterub and R.B. Sund. 1995. Antioxidant activity of fruit exudate and C-methylated dihydrochalcones from Myrica gale. Planta Med. 61: 515-518.
117. Mathiesen, E., D. Diallo, M. Andersen and K.E. Malterud. 2002. Antioxidants from the bark of Burkea africana an African medicinal plant. Phytother. Res. 16: 148-153.
118. Matsuda, H., Y. Li, T. Murakami, N. Matsumura, J. Yamaharah and M. Yoshikawa. 1998. Antidiabetic principle of natural medicines, III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chem. Pharm. Bull. 46: 1399-1403.
119. Matsui, T., S. Ebuchi, M. Kobayashi, K. Fukui, K. Sugita, N. Terahara and K. Matsumoto. 2002. Anti-hyper-glycemic effect of diacylated anthocyanin from Ipomea batatas cultivar Ayamurasaki can be achieved by through the α-glucosidase inhibitory action. J. Agric. Food Chem. 50: 7244-7248.
120. Matsuur, H., C. Asakawa, M. Kurimoto and J. Mizytani. 2002. Alpha-glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa. Biosci. Biotech. Biochem. 66: 1576-1578.
121. McCue, P., D. Vattem and K. Shetty. 2004. Inhibitory effect of clonal oregano extracts against porcine pancreatic amylase in vitro. Asia Pac. J. Clin. Nutr. 13: 401-408.
122. Mcdougall, G., F. Shapiro, P. Dobson, P. Smith, A. Blake and D. Stewart. 2005. Different polyphenolic components of soft fruits inhibit α-amylase and α-glucosidase. J. Agric. Food Chem. 53: 2760-2766.
123. Melzig, M.F. and I. Funke. 2007. Inhibitors of alpha-amylase from plants- a possibility to treat diabetes mellitus type 2 by phytotherapy. Wien. Med. Wochenschr. 157: 320-4.
124. Mesaik, M.A., S. Rahat, K.M. Khan, Z. Zia-Ullah, M.I. Choudhary, S. Murad, Z. Ismail, A. Ur-Rahman and A. Ahmad. 2004. Synthesis and immunomodulatory properties of selected oxazolone derivatives. Bioorg. Med. Chem. 2: 2049-2057.
125. Mesaik, M.A., Z. Ul-Haq, S. Murad, Z. Ismail, N.R. Abdullah, H.K. Gill, A. Ur-Rahman, M. Yousaf, R.A. Siddiqui, A. Ahmad and M.I. Choudhary. 2006. Biological and molecular docking studies on coagulin-H: Human IL-2 novel natural inhibitor. Mol. Immunol. 43(11): 1855-1163.
126. Mooradian, A.D. and J. Thurman. 1999. Drug therapy of postprandial hyperglycemia. Drugs 57: 19-29.
127. Mousavi, S.H., N.Z. Tayarani and H. Parsaee. 2010. Protective effect of saffron extract and crocin on reactive oxygen species-mediated high glucose-induced toxicity in PC12 cells. Cell Mol. Neurobiol. 30: 185-191.
128. Murakami, T., A. Emoto, H. Matsuda and M. Yoshikawa. 2001. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a,-b,-c,-d,-e,-f,-g and -h, and new oleanane-type triterpene saponins, goyaglycosides I, II and III, from the fresh fruit of Japanese Momordica charantia. L. Chem. Pharm. Bull. 49: 54-63.
129. Musabayane, C.T., N. Mahlalela, F.O. Shode and J.A.O. Ojewole. 2005. Effects of Syzygium cordatum (Hochst) [Myrtaceae] leaf extract on plasma glucose and hepatic glycogen in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 97: 485-490.
130. Nammi, S., M. Boini, S. Lodagala and R. Bahara. 2003. The juice of fresh leaves of C. roseus Linn. Reduces blood glucose in normal and alloxan diabetic rabbits. BMC Comp. Alter. Med. 3: 1-4.
131. Nessar, A. 2005. Advanced glycation end products-role in pathology of diabetic complications. Diab. Res. Clin. Prac. 67: 3-21.
132. Nistor Baldea, L., L.C. Martineau, A. Benhaddou-Andaloussi, J.T. Arnason, E. Lévy and P.S. Haddad. 2010. Inhibition of intestinal glucose absorption by anti-diabetic medicinal plants derived from the James Bay Cree traditional pharmacopeia. J. Ethnopharmacol. 132: 473-482.
133. Nickavar, B. and N. Yousefian. 2009. Inhibitory effects of six allium species on α-amylase enzyme activity. Iran. J. Pharm. Res. 8: 53-57.
134. O’Dowd, Y., F. Driss, P.M.C. Dang, C. Elbim, M.A. Gougerot-Pocidalo, C. Pasquire and A. El-Benna. 2004. Antioxidant effect of hydroxytyrosol, a polyphenol from olive oil: scavenging of hydrogen peroxide but not superoxide anion produced by human neutrophils. Biochem. Pharmacol. 68: 2003-2008.
135. Oh, W.K., C.H. Lee, M.S. Lee, E.Y. Bae, C.C.B. Sohn, H. Oh, B.Y. Kim and J.S. Ahn. 2005. Antidiabetic effects of extracts from Psidium guajava. J. Ethnopharmacol. 96: 411-415.
136. Okada, T., T. Kawano, T. Sakakibara, O. Hazeki and M. Ui. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and anti-lipolysis in rat adipocytes-studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-3573.
137. Ong, K.C. and H.E. Khoo. 1996. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem. Pharmacol. 51: 423-429.
138. Patwardhan, B. 2005. Ethnopharmacology and drug discovery. J. Ethnopharmacol. 100:50-52.
139. Pawar, R.S. and K.K. Bhutani. 2004. Madhucosides A and B, Protobassic Acid Glycosides from Madhuca indica with Inhibitory Activity on Free Radical Release from Phagocytes. J. Nat. Prod. 67: 668-671.
140. Peppa, M., J. Uribarri and H. Vlassara. 2003. Glucose, advanced glycation end products, and diabetes complications: What is new and what works. Clin. Diab. 21: 186-187.
141. Perl, M. and H. Hikino. 1989. Effect of some hypoglycemic glycans on glucose uptake and glucose metabolism by inverted intestinal fragments. Phytother. Res. 3: 207-208.
142. Phillipson, D. 1994. Natural products as drugs. Transaction of Royal Society Med. Hyg. 88:17-19.
143. Pieters, L. and A.J. Vlietinck. 2005. Bioguided isolation of pharmacologically active plant components, still a valuable strategy for the finding of new lead compounds. J. Ethnopharmacol. 100: 57-60.
144. Platel, K. and K. Srinivasen. 1997. Plant foods in the management of Diabetes mellitus:vegetables as potential hypoglycemic agents. Nahrung 41: 68-74.
145. Poitout, V., L.K. Olson and R.P. Robertson. 1996a. Insulin-secreting cell lines: classification, characteristics and potential applications. Diab. Metab. 22: 7-14.
146. Poitout, V., L.K. Olson and R.P. Robertson. 1996b. Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J. Clin. Invest. 15: 97: 1041-6.
147. Ponnusamy, S., R. Ravindra, S. Zinjarde, S. Bhargava and S.A. Ravi Kumar. 2011. Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evid. Based Comp. Altern. Med. Article ID 515647: 2011. Epub 2010 Sep 23.
148. Prashanth, D., D. Samiullah and R. Padamaja. 2001. Effect of certain plant extracts on alpha amylase activity. Fitoterap. 72: 179-181.
149. Puls, W. and U. Keup. 1973. Influence of an alpha amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man. Diabetol. 9: 97-101.
150. Pullela, S.V., A.K. Tiwari, U.M.S. Vanka, A. Vummenthula, H.B. Tatipaka, K.R. Dasari, I.A. Khan and M.R. Janaswamy. 2006. HPLC assisted chemobiological standardization of α-glucosidase-I enzyme inhibitory constituents from Piper longum Linn-An Indian medicinal plant. J. Ethnopharmacol. 108: 445-449.
151. Ramakrishna, V. and R. Jailkhani. 2007. Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diag. Path. 2: 22.
152. Raman, A. and C. Lau. 1996. Antidiabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicines 2: 349-362.
153. Rangasamy, O., G. Raoelison, F.E. Rakotoniriana, K. Cheuk, S. Urverg-Ratsimamanga, J. Quetin-Leclercq, A. Gurib-Fakim and A.H. Subratty. 2007. Screening for anti-infective properties of several medicinal plants of the Mauritians flora. J. Ethnopharmacol. 109: 331-337.
154. Ranilla, L.G., Y. Kwon, E. Apostolidis, K. Shetty, O. Rau, M. Wurglics, T. Dingermann, M. Abdel-Tawab and M. Schubert-Zsilavecz. 2010. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America Screening of herbal extracts for activation of the human peroxisome proliferator activated. Bio. Techno. 101: 4676-4689.
155. Rau, O., M. Wurglics, T. Dingermann, M. Abdel-Tawab and M. Schubert-Zsilavecz. 2006. Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Pharmazie. 61: 952-956.
156. Rokeya, B. 2005. Plant materials as a source of potential antidiabetic agents. In: Diabetes mellitus epidemic combat the challenge. Tata McGraw-Hill Publishing Company Ltd. ND, India.
157. Rchid, H., H. Chevassus, R. Nmila, C. Guiral, P. Petit, M. Chokaıri and Y. Sauvaire. 2004. Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets receptor. Fund. Clin. Pharmacol. 18: 525-529.
158. Reed, M.I. and K.A. Scribner. 1999. In-vivo and in-vitro models of type 2 diabetes in pharmaceutical discovery. Diab. Obes. Metab. 1: 75-76.
159. Rosenberg, I. 1982. Starch blockers- still no calorie lunch. The New Eng. J. Med. 2:1444-1445.
160. Rotshteyn, Y. and S. Zito. 2004. Application of modified in vitro screening procedure for identifying herbals possessing sulfonylureas-like activity. J. Ethnopharmacol. 93:337-344.
161. Saeed, F.A. and G.A. Castle. 1998. Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: Implications for diabetic susceptibility to infections. Clin. Diag. Lab. Immunol. 5: 740-743.
162. Sahib, N.J., A.A. Hamid, D. Kitts, M. Purnama, N. Saari and F. Abas. 2011. The effects of Morinda citrifolia, Momordica charantia and Centella asiatica extracts on lipoprotein lipase and 3t3-l1 preadipocytes. J. Food Biochem. 35: no. doi: 10.1111/j.1745-4514.2010.00444.x
163. Saltiel, A.R. and C.R. Kahn. 2001. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 41: 799-806.
164. Saraswat, M., P. Muthenna, P. Suryanarayana, J.M. Petrash and G.R. Bhanuprakash. 2008. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pac. J. Clin. Nutr. 17: 558-565.
165. Schneider, I. and F. Bucar. 2005. Lipoxygenase inhibitors from natural plant sources. Part 1: medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase/cyclooxygenase. Phytother. Res. 19: 81-102.
166. Schultz, K., L.M. Rasmussen and T. Ledet. 2005. Expression levels and functional aspects of the hyaluronan receptor CD44. Effects of insulin, glucose, IGF-I, or growth hormone on human arterial smooth muscle cells. Metabolism 54: 287-295.
167. Schwartz, C.J., A.J. Valente, E.A. Sprague, J.L. Kelley, A.J. Cayatte and M.M. Rozek. 1992. Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus. Diab. Care 15: 1156-1167.
168. Shimaya, A., E. Kurosaki, K. Shioduka, R. Nakano, M. Shibasaki and H. Shikama. 1998. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes. Horm. Metab. Res. 30: 543-548.
169. Shimizu, K., M. Ozeki, A. Iino, S. Nakajyo, N. Urakaw and M. Atsuchi. 2001. Structure-activity relationships of triterpenoid derivatives extracted from Gymnema inodorum leaves on glucose absorption. Jap. J. Pharmacol. 86: 223-9.
170. Silverstein, L.J., B.G. Swahsoh and D.F. Moffetta. 1996. Procyanidin from Black Beans (Phaseolus vulgaris) inhibits nutrient and electrolyte absorption in isolated rat ileum and induces secretion of chloride ion. J. Nutr. 126: 1688-1695.
171. Simoes, L.M.C., L.E. Gregório, A.A. Da Silva Filho, M. De Souza, A.E. Azzolini, J.K. Bastos and Y.M. Lucisano-Valim. 2004. Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. J. Ethnopharmacol. 94: 59-65.
172. Söderberg, S., P. Zimmet, J. Tuomilehto, M. Courten, G.K. Dowse, P. Chitson, H. Gareeboo, K.G.M. Alberti and J.E. Shaw. 2005. Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius. Diab. Med. 22: 61-68.
173. Soumyanath, A. and S. Srijayanta. In vitro models for assessing antidiabetic activity. In:Soumyanath A (ed.). 2006. Traditional medicines for modern times: antidiabetic plants. CRC Press. Boca Raton, USA.
174. Srijayanta, P.M., J.S. Persaud and L.A. Raman. 1998. In vitro screening of medicinal plants for potential antidiabetic effects. J. Pharm. Pharmacol. 50: 219.
175. Srijayanta, S., J. O’Reilly, A. Raman and H. Wiseman. 1999. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother. Res. 13: 601-608.
176. Steinberg, D. 1999. At last, direct evidence that lipoxygenases play a role in atherogenesis. J. Clin. Invest. 103: 1487-1488
177. Subramanian, R., M.Z. Asmawi and A. Sadikun. 2008. In vitro α-glucosidase and α- amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochimica. Pol. 55: 391-398.
178. Subratty, A.H. 2003. A kinetic model for in-vitro intestinal uptake of the amino acid L-tyrosine across rat everted gut sacs. Discov. Innov. 15: 10-14.
179. Suryanarayana, P., P.A. Kumar, M. Saraswat, M. Petrash and G.R. Bhanuprakash. 2004. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: Implications for the prevention of sugar cataract. Mol. Vision. 10: 148-54.
180. Suzuki, R., Y. Okada and T. Okuyama. 2003. Two flavone c-glycosides from the style of Zea mays with glycation inhibitory activity. J. Nat. Prod. 66: 564-565.
181. Suzuki, Y.A., Y. Murata, H. Inui, M. Sugiura and Y. Nakano. 2005. Triterpene glycosides of Siraitia grosvenori inhibit rat intestinal maltase and suppress the rise in plasma glucose level after single oral administration of maltose in rats. J. Agric. Food Chem. 53:2941-2946.
182. Tadashi, S., F. Shinsaku, L. Qiang, F. Yoshihiro, S. Nakaji and K. Sugawara. 2003. Characteristics of attenuating effects of rebamipide, an anti-ulcer agent, on oxidative burst of human neutrophils. J. Pharmacol. Sci. 91: 153-157.
183. Talalay, P. and P. Talalay. 2001. The importance of using scientific principles in the development of medicinal plants. Acad. Med. 76: 238-247.
184. Tandon, S., M. Das and S.K. Khanna. 1993. Effect of sanguinarine on the transport of essential nutrients in an everted gut sac model: Role of Na+/K+-ATPase. Nat. Toxin. 1: 235-240.
185. Tang, S.W., M. Whiteman, Z.F. Peng, A. Jenner, L. Yong and B. Halliwell. 2004. Characterisation of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines. Free Rad. Bio. Med. 36: 1575-1587.
186. Tarpey, M.M. and I. Fridovich. 2001. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ. Res. 89: 224-236.
187. Taylor, S. 1999. Deconstructing type 2 diabetes. Cell 97: 9-12.
188. Tiwari, A. and R. Madhusudana. 2002. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Cur. Sci. 83: 30-38.
189. Tomimatsu, T. and T. Horie. 2005. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil. Chemico-Biol. Interac. 155: 129-139.
190. Toskulkao, C., F. Sutheerawattananon and P. Piyachaturawat. 1995. Inhibitory effect of steviol, a metabolite of stevioside, on glucose absorption in everted hamster intestine in vitro. Toxicol. 80: 153-159.
191. Ueda, H., K. Kawanishi and M. Moriyasu. 2004. Effects of ellagic acid and 2-(2,3,6-trihydroxy-4-carboxyphenyl)ellagic acid on sorbitol accumulation in vitro and in vivo. Biol. Pharm. Bull. 27: 1584-1587.
192. Van Huijsduijnen, R.H., A. Bombrun and D. Swinnen. 2002. Selecting protein tyrosine phosphatases as drug targets. Drug Dis. Today 7: 1013-1019.
193. Van de Venter, M., S. Roux, L.C. Bungu, J. Louw, N.R. Crouch, O.M. Grace, V. Maharaj, P. Pillay, P. Sewnarian, N. Bhagwandin and P. Folb. 2008. Antidiabetic screening and scoring of 11 plants traditionally used in South Africa. J. Ethnopharmacol. 119: 81-86.
194. Vats, V., K. Grover and S. Rathi. 2002. Evaluation of T. foenum-graecum Linn, O. sanctum, P. marsupium in normal and alloxanised diabetic rats. J. Ethnopharmacol. 79: 95-100.
195. Vedavanam, K., S. Srijayanta, J. O’Reilly, A. Raman and H. Wiseman. 1999. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother. Res. 13: 601-608.
196. Vuksan, V., J.L. Sievenpiper, Z. Xu, E.Y.Y. Wong, A. Jenkins, U. Beljan-zdravkovic, L.A. Leiter, R.G. Josse and M.P. Stavro. 2001. Konjac-Mannan and American ginsing: Emerging alternative therapies for type 2 diabetes mellitus. J. Amer. Col. Nutri. 20: 370S-380S.
197. Welihinda, J. and E.H. Karunanayake. 1986. Extrapancreatic effects of Momordica charantia in rats. J. Ethnopharmacol. 17: 247-255.
198. Wilson, T.H. and G. Wiseman. 1954. The use of sacs of everted small intestine for the study of transference of substances from the mucosal to the serosal surface. J. Physiol. 123:116-125.
199. Wiernsperger, N.F. 2003. Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diab. Metabol. 29: 579-585.
200. Winkelman, M. 1989. Ethno-Botanical treatments of diabetes in Baja California North. Med. Anthropol. 11: 255-68.
201. Witko-Sarsat, V., V. Gausson, A. Nguyen, M. Touam, T. Drueke, F. Santangelo and B. Descamps-Latscha. 2003. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney Internat. 64: 82-91.
202. World Health Organization Regional Office for the Western Pacific. 1993. WHO’s Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines.
203. World Health Organization. 2003. WHO Expert Committee on Specifications for Pharmaceutical Preparations (WHO Technical Report Series, no. 908).
204. World Health Organization. 2005. Good Manufacturing Practices: Updated Supplementary Guidelines for the Manufacture of Herbal Medicines (working document QAS/04.050/ Rev. 3).
205. World Health Organization. 2007. Diabetes Prevention and Control: A Strategy for the WHO African Region: Report of the Regional Director: Fifty-seventh Session, Brazzaville, Republic of Congo, 27-31 August 2007.
206. Wright, E.M. 1993. The intestinal Na+/glucose cotransporter. Ann. Rev. Physiol. 55:575-589.
207. Yadav, S., V. Vats, Y. Dhunnoo and J.K. Grover. 2002. Hypoglycemic and antihyperglycemic activity of Murraya koenigii leaves in diabetic rats. J. Ethnopharmacol. 82: 111-116.
208. Yamagishi, S., K. Nakamura, H. Inoue, S. Kikuchi and M. Takeuchi. 2005. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients. Med. Hypo. 64: 1208-1210.
209. Yeh, G., D. Eisenberg, T. Kapchuk and R. Phillips. 2003. Systematic review of herbs and dietary supplements for glyceamic control in diabetes. Diab. Care 26: 1277-1294.
210. Yesilada, E., I. Gurbuz and H.J. Shibata. 1999. Momordica charantia: An overview. J. Ethnopharmacol. 66: 289-293.
211. Yong-Mu, K., W.M. Myeong-Hyeong and R. Hae-IK. 2004. A novel α-glucosidase inhibitor from pine bark. Carb. Res. 339: 715-717.
212. Yoon, M., H. Lee, S. Jeong, J.J. Kim, C.J. Nicol, K.W. Nam, M. Kim, B.G. Cho and G.T. Oh. 2003. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng. Brit. J. Pharmacol. 138: 1295-1302.
213. Yoshikawa, M., T. Marakami and H. Matsuda. 1997. Medicinal foodstuffs. X. Structures of new triterpene glycosides, gymnemosides -c, -c, -e, and -f, from the leaves of Gymnema sylvestre R. Br: influence of gymnema glycosides on glucose uptake in rat small intestinal fragments. Chem. Pharm. Bull. 45: 2034-2038.
214. Youn, J.Y., H.Y Park and K.H. Cho. 2004. Anti-hyperglycemic activity of Commelina communis L, inhibition of α-glucosidase. Diab. Res. Clin. Prac. 66S: S149-S155.
215. Zhang, B., G. Salituro, D. Szalkowski, Z. Li, Y. Zhang, I. Royo, D. Vilella, M.T. Diez, F. Pelaez, C. Ruby, R.L. Kendall, X. Mao, P. Griffin, J. Calaycay, J.R. Zierath, J.V. Heck, R.G. Smith and D.E. Moller. 1999. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Sci. 284: 974-977.
216. Zhao, M., S.A. Amiel, M.R. Christie, M. Rela, N. Heaton and G.C. Huang. 2005. Insulinproducing cells derived from human pancreatic non-endocrine cell cultures reverse streptozotocin-induced hyperglycemia in mice. Diabetol. 48: 2051-2061.
217. Zhu, Y.Z., S.H. Huang, B.K. Tan, J. Sun, M. Whitemen and Y.C. Zhu. 2004. Antioxidants in Chinese herbal medicines: a biochemical perspective. Nat. Prod. Res. 21: 478-89.